Less suited for patients with complex medical situations who benefit from hands-on monitoring
Acquisitions On June 11th Novo Nordisk announced the $2.1B acquisition of Corvidia Therapeutics and their lead candidate ziltivekimab, which is a monocloncal antibody targeting IL-6 and reducing cardiovascular events
After stroke, NPCs have the ability to migrate to the lesion site, and chemokines and IGF-1 can promote NPCs proliferation, migration, and differentiation (101, 102)
Canagliflozin and cardiovascular and renal events in Type 2 diabetes
Manufactured under current Good Manufacturing Practice (cGMP) standards
How it may help psoriasis: Reduces TNF- and other pro-inflammatory cytokines Promotes angiogenesis (new blood vessel formation) for tissue repair Accelerates wound healing and epithelial regeneration Modulates nitric oxide pathways Research context: Animal studies show BPC-157 reduces inflammation in various models